170
Views
7
CrossRef citations to date
0
Altmetric
Commentaries

Immunochemotherapy in Waldenström macroglobulinemia – still the backbone of treatment

&
Pages 2489-2490 | Received 15 May 2015, Accepted 16 May 2015, Published online: 21 Sep 2015

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Magdalini Migkou, Despina Fotiou, Maria Gavriatopoulou & Meletios Athanasios Dimopoulos. (2021) Ibrutinib plus rituximab for the treatment of adult patients with Waldenström’s macroglobulinemia: a safety evaluation. Expert Opinion on Drug Safety 20:9, pages 987-995.
Read now
Maria Gavriatopoulou, Despina Fotiou, Ioannis Ntanasis-Stathopoulos & Meletios Athanasios Dimopoulos. (2020) The current role of BTK inhibitors in the treatment of Waldenstrom’s Macroglobulinemia. Expert Review of Anticancer Therapy 20:8, pages 663-674.
Read now
Aristea-Maria Papanota, Ioannis Ntanasis-Stathopoulos, Efstathios Kastritis, Meletios A Dimopoulos & Maria Gavriatopoulou. (2019) Evaluating ibrutinib in the treatment of symptomatic Waldenstrom’s macroglobulinemia. Journal of Blood Medicine 10, pages 291-300.
Read now

Articles from other publishers (4)

Suzanne O. Arulogun, Duncan Brian, Harshita Goradia, Aaron Cooney, Tobias Menne, RayMun Koo, Aideen T. O'Neill, Josephine M. I. Vos, Guy Pratt, Deborah Turner, Kirsty Marshall, Kate Manos, Claire Anderson, Maria Gavriatopoulou, Charalampia Kyriakou, Marie J. Kersten, Monique C. Minnema, Eirini Koutoumanou, Dima El‐Sharkawi, Kim Linton, Dipti Talaulikar, Helen McCarthy, Mark Bishton, George Follows, Ashutosh Wechalekar & Shirley P. D'Sa. (2023) Bendamustine plus rituximab for the treatment of Waldenström Macroglobulinemia: Patient outcomes and impact of bendamustine dosing. American Journal of Hematology 98:5, pages 750-759.
Crossref
Ghazi Elamin, Aimen Aljoundi & Mahmoud E. S. Soliman. (2022) Co‐Binding of JQ1 and Venetoclax Exhibited Synergetic Inhibitory Effect for Cancer Therapy; Potential Line of Treatment for the Waldenström Macroglobulinemia Lymphoma. Chemistry & Biodiversity 19:7.
Crossref
Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Despina Fotiou & Meletios A. Dimopoulos. (2021) Current and novel BTK inhibitors in Waldenström’s macroglobulinemia. Therapeutic Advances in Hematology 12, pages 204062072198958.
Crossref
Véronique LeblondEfstathios KastritisRanjana AdvaniStephen M. AnsellChristian BuskeJorge J. CastilloRamón García-SanzMorie GertzEva KimbyCharalampia KyriakouGiampaolo MerliniMonique C. MinnemaPierre MorelEnrica MorraMathias Rummel, Ashutosh Wechalekar, Christopher J. PattersonSteven P. TreonMeletios A. Dimopoulos. (2016) Treatment recommendations from the Eighth International Workshop on Waldenström’s Macroglobulinemia. Blood 128:10, pages 1321-1328.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.